B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: A novel peptide vaccine candidate

Microbiology and Immunology

Volumn 55, Issue 4, 2011, Pages 247-253

  Wan, Cheng song ^a   Zhou, Yong ^b   Yu, Yang ^a   Peng, Li juan ^a   Zhao, Wei ^a   Zheng, Xue li ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Center for Diseases Prevention and Control of Guangzhou   (China)

Author keywords

Enterohemorrhagic escherichia coli O157:H7; Epitope; Intimin; Vaccine candidate

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTIMIN; KEYHOLE LIMPET HEMOCYANIN; PEPTIDE KT 12; PEPTIDE VACCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BETA TURN; CONTROLLED STUDY; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; FEMALE; HYDROPHILICITY; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SURVIVAL RATE;

ADHESINS, BACTERIAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; FEMALE; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA;

ESCHERICHIA COLI; MUS;

EID: 79953081056     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00316.x     Document Type: Article

References (22)

1. Riley L.W., Remis R.S., Helgerson S.D., McGee H.B., Wells J.G., Davis B.R., Hebert R.J., Olcott E.S., Johnson L.M., Hargrett N.T., Blake P.A., Cohen M.L. (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308: 681-5.
2. Rangel J.M., Sparling P.H., Crowe C., Griffin P.M., Swerdlow D.L. (2005) Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 11: 603-9.
3. National Institute of Health and Infectious Diseases Control Division, Ministry of Health and Welfare of Japan. (1997) Verocytotoxin-producing Escherichia coli (enterohemorrhagic E.coli) infections, Japan, 1996-June 1997. Infectious Agents Surveillance Report 18: 153-4.
4. Zou Q.M. (2004) Research progress in preventing and curing enterohemorrhagic Escherichia coli infection. J Microbiol (in China) 5: 96-8.
5. Oklahoma State Department of Health, epidemiology bulletin, winter 2006, vol 38, no. 4.
6. Mellies J.L., Elliott S.J., Sperandio V., Donnenberg M.S., Kaper J.B. (1999) The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol Microbiol 33: 296-306.
7. McKee M.L., O'Brien A.D. (1996) Truncated enterohemorrhagic Escherichia coli (EHEC) O157:H7 intimin (EaeA) fusion proteins promote adherence of EHEC strains to HEp-2 cells. Infect Immun 64: 2225-33.
8. McKee M.L., O'Brien A.D. (1995) Investigation of enterohemorrhagic Escherichia coli O157:H7 adherence characteristics and invasion potential reveals a new attachment pattern shared by intestinal E. coli. Infect Immun 63: 2070-4.
9. Ebel F., Podzadel T., Rohde M., Kresse A.U., Krämer S., Deibel C., Guzmán C.A., Chakraborty T. (1998) Initial binding of Shiga toxin-producing Escherichia coli to host cells and subsequent induction of actin rearrangements depend on filamentous EspA-containing surface appendages. Mol Microbiol 30: 147-61.
10. Son W.G., Graham T.A., Gannon V.P. (2002) Immunological characterization of Escherichia coli O157:H7 intimin gamma1. Clin Diagn Lab Immunol 9: 46-53.
11. Dean-Nystrom E.A., Gansheroff L.J., Mills M., Moon H.W., O'Brien A.D. (2002) Vaccination of pregnant dams with intimin (O157) protects suckling piglets from Escherichia coli O157:H7 infection. Infect Immun 70: 2414-8.
12. Judge N.A., Mason H.S., O'Brien A.D. (2004) Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces. Infect Immun 72: 168-75.
13. Yi Y., Zou Q.M., Cheng J.P., Mao X.H., Tong W.D., Zeng M., Zhu Y.H., Ma Y., Wang Q.X. (2005) Construction and prokaryotic expression of the fusion protein Stx2B-IntiminC300 of EHEC O157: H7 and its immunoprophylactic potential. Chinese J Microbiol. Immun 25: 227-33.
14. Hopp T.P., Woods K.R. (1981) Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A 78: 3824-8.
15. Chou P.Y., Fasman G.D. (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47: 45-148.
16. Karplus P.A., Schultz G. (1985) Prediction of chain flexibility in proteins. Naturwissenschaften 72: 212-3.
17. Emini E.A., Hughes J.V., Perlow D.S., Boger J. (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55: 836-9.
18. Jameson B.A., Wolf H. (1988) The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 4: 181-6.
19. Kolaskar A.S., Tongaonkar P.C. (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276: 172-4.
20. Adu-Bobie J., Trabulsi L.R., Carneiro-Sampaio M.M., Dougan G., Frankel G. (1998) Identification of immunodominant regions within the C-terminal cell binding domain of intimin alpha and intimin beta from enteropathogenic Escherichia coli. Infect Immun 66: 5643-9.
21. Conlan J.W., Cox A.D., KuoLee R., Webb A., Perry M.B. (1999) Parenteral immunization with a glycoconjugate vaccine containing the O157 antigen of Escherichia coli O157:H7 elicits a systemic humoral immune response in mice, but fails to prevent colonization by the pathogen. Canadian J Microbiol 45: 279-86.
22. Zhang Y., Lu S.Q., Zhang Y.Z., Zhao B.X., Xu J.G. (2004) The study for the immuno-protection of E. coli O157:H7 outer membrane protein. Zhonghua Yi Xue Za Zhi (in Chinese) 84: 58-62.